Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1125.61%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
-853.60%
NET PROFIT MARGIN AVG 3Y
-795.45%
NET PROFIT MARGIN AVG 5Y
-887.93%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CytoMed Therapeutics Limited
Market Cap
$10.75M
Net Profit Margin
N/A
TTM Avg
-853.60%
3Y Avg
-795.45%
5Y Avg
-887.93%
Market Cap
$10.81M
Net Profit Margin
-620.70%
TTM Avg
-326.13%
3Y Avg
-2493.66%
5Y Avg
-2115.74%
Market Cap
$10.52M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.04M
Net Profit Margin
-13.78%
TTM Avg
-36.44%
3Y Avg
-33.55%
5Y Avg
-58.16%
Market Cap
$11.30M
Net Profit Margin
0.00%
TTM Avg
11.23%
3Y Avg
5.62%
5Y Avg
-9479.86%
Market Cap
$10.15M
Net Profit Margin
-141.28%
TTM Avg
-101.58%
3Y Avg
-179.50%
5Y Avg
-204.48%
Market Cap
$11.38M
Net Profit Margin
-14621.00%
TTM Avg
-5877.48%
3Y Avg
-2938.74%
5Y Avg
-1959.16%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $10.75M | N/A | -853.60% | -795.45% | -887.93% |
| Cerenome, Inc. (CNSY)vs › | $10.81M | -620.70% | -326.13% | -2493.66% | -2115.74% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioVie Inc. (BIVI)vs › | $11.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.04M | -13.78% | -36.44% | -33.55% | -58.16% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | 0.00% | 11.23% | 5.62% | -9479.86% |
| Lifeward Ltd. (LFWD)vs › | $10.15M | -141.28% | -101.58% | -179.50% | -204.48% |
| MetaVia Inc. (MTVA)vs › | $10.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.38M | -14621.00% | -5877.48% | -2938.74% | -1959.16% |
| Caring Brands, Inc. (CABR)vs › | $10.09M | -666037.76% | -148948.78% | -148948.78% | -148948.78% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1125.61% |
| 2025-12-31 | -1030.69% |
| 2025-09-30 | -423.42% |
| 2025-06-30 | -834.68% |
| 2025-03-31 | -834.69% |
| 2024-12-31 | -2055.11% |
| 2024-09-30 | -511.59% |
| 2024-06-30 | -977.37% |
| 2024-03-31 | -485.50% |
| 2023-12-31 | -883.53% |
| 2023-09-30 | -883.54% |
| 2023-06-30 | -759.31% |
| 2023-03-31 | -759.30% |
| 2022-12-31 | -1419.87% |
| 2022-09-30 | -738.14% |
| 2022-06-30 | -2717.86% |
| 2022-03-31 | -1335.20% |
| 2021-12-31 | -2397.86% |
| 2021-09-30 | -1204.39% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | -3582.65% |
| 2020-12-31 | -2364.82% |
| 2020-09-30 | -2364.76% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
